Novartis - 2/28

Entry	Author	Date	Location
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug	Luke Timmerman	07/21/11	San Diego
Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials	Bruce V. Bigelow	07/18/11	San Diego
Allozyne Looks to Rustle Up Interest on Wall Street With Backdoor IPO	Luke Timmerman	07/13/11	Seattle
Idera Takes Beating on Loss of Merck KGaA Cancer Collaboration, But Remains Committed to Toll-Like Receptors	Arlene Weintraub	07/13/11	Boston
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul	Luke Timmerman	07/05/11	Seattle
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments	Arlene Weintraub	05/17/11	New York
Drugs that Melt in Your Mouth: MonoSolRx Has Its Sights Set on Oral Insulin	Arlene Weintraub	05/11/11	New York
My 33 Months at Xconomy, a Nano-Memoir (of Sorts)	Ryan McBride	04/29/11	Boston
Biogen Shares Jump on Good News on Revenue, Oral MS Drug	Ryan McBride	04/21/11	Boston
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area	Luke Timmerman	04/19/11	San Francisco
Atlas and Monsanto the Latest VC and Big Co. Getting Close	Ryan McBride	04/14/11	Boston
Roche Vet Takes CEO Job at Boston’s Enlight Biosciences	Ryan McBride	04/12/11	Boston
Biogen Idec Passes Pivotal Trial With Oral MS Drug; Shares Climb	Luke Timmerman	04/11/11	Boston
Blueprint Medicines Brings In $40M, Led by Third Rock, for Targeted Cancer Therapies	Gregory T. Huang	04/11/11	Boston
Bigger Isn’t Better: It’s Time for Big Pharma to Break Up Into Little Pharma	Luke Timmerman	03/28/11	National
Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation	Ryan McBride	03/23/11	Boston
Alnylam, UMass, and Others Settle RNAi Patent Litigation	Ryan McBride	03/15/11	Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche	Ryan McBride	03/03/11	Boston
FDA Wants More Data on Merck KGaA’s MS Pill As Biogen Develops Rival Therapy	Ryan McBride	03/02/11	Boston
ImmunoGen CEO Highlights Two New Souped-Up Antibodies Against Cancer	Ryan McBride	02/25/11	Boston
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV	Luke Timmerman	02/23/11	Seattle
Secretive Biotech Arsanis Raises $9.6M	Ryan McBride	02/08/11	Boston
How Sanofi Could Start Off on the Right Foot in Cambridge	Steve Dickman	02/07/11	Boston
Vitality Acquired By Healthcare Investor Soon-Shiong, Looks to Expand Wireless Products for Improving Healthy Behaviors	Erin Kutz	02/02/11	Boston
The World’s Most Innovative City	Tim Rowe	02/02/11	Boston
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News	Bruce V. Bigelow	01/27/11	San Diego
Genoptix Agrees to $470M Takeover by Novartis	Luke Timmerman	01/24/11	San Diego
Dana-Farber Scientists Leave Board of Startup in Legal Battle with Cancer Center	Ryan McBride	01/21/11	Boston
Sanford-Burnham Strikes Deal With J&J, Second Big Pharma Alliance in a Month	Luke Timmerman	01/17/11	San Diego
Page 2 of 10	« previous page · next page »

Entry

Author

Date

Location

Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug

Luke Timmerman

07/21/11

San Diego

Encouraged by Early Work on Anti-Cancer Drug, Intellikine Hires New Head for Clinical Trials

Bruce V. Bigelow

07/18/11

San Diego